Boussard & Gavaudan Gestion Sas Purchases New Shares in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas purchased a new position in shares of Integer Holdings Corporation (NYSE:ITGR) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Boussard & Gavaudan Gestion Sas owned approximately 0.08% of Integer as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in ITGR. Irenic Capital Management LP bought a new position in shares of Integer in the fourth quarter worth about $99,109,000. Alliancebernstein L.P. grew its stake in shares of Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after purchasing an additional 993,810 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Integer by 1,141.6% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock valued at $72,076,000 after purchasing an additional 753,081 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Integer by 3,350.2% in the fourth quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock valued at $53,106,000 after purchasing an additional 657,483 shares in the last quarter. Finally, The Manufacturers Life Insurance Company bought a new position in Integer in the 2nd quarter worth approximately $50,925,000. Institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

Shares of Integer stock opened at $125.30 on Friday. The firm has a fifty day moving average of $107.58 and a two-hundred day moving average of $94.48. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. The stock has a market capitalization of $4.26 billion, a price-to-earnings ratio of 34.24, a PEG ratio of 2.96 and a beta of 0.61. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $126.14.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The business had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. During the same period last year, the company earned $1.55 EPS. The firm’s revenue was down 2.6% on a year-over-year basis. As a group, equities research analysts predict that Integer Holdings Corporation will post 6.09 EPS for the current year.

Analyst Ratings Changes

Several research firms have issued reports on ITGR. HC Wainwright reaffirmed a “buy” rating on shares of Integer in a report on Friday, July 24th. Wells Fargo & Company boosted their target price on Integer from $84.00 to $127.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 4th. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research note on Monday, August 3rd. Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Finally, Benchmark lowered Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $109.86.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.